| HOME >> BIOLOGY >> TECHNOLOGY |
HD Therapy 232 216 7% (2%)
--------------------------------------------------------------------------
Total Renal $1,156 $1,078 7% (1%)
--------------------------------------------------------------------------
--------------------------------------------------------------------------
Baxter excluding Transfusion Therapies $5,980 $5,369 11% 5%
--------------------------------------------------------------------------
--------------------------------------------------------------------------
Transfusion Therapies (3) $86 $135 (36%) (39%)
--------------------------------------------------------------------------
--------------------------------------------------------------------------
TOTAL BAXTER $6,066 $5,504 10% 3%
==========================================================================
(1) Previously referred to as BioSurgery.
(2) Principally includes vaccines, sales of plasma to third parties, and
recombinant FIX (BeneFIX). Sales of BeneFIX ceased as of June 30,
2007.
(3) The results of operations of the TT business were previously reported
in the BioScience business. The TT business was sold on February 28,
2007. The TT totals above include sales of TT products through the
date of divestiture, as well as revenues associated with
manufacturing, distribution and other services provided by the company
to the buyer of the TT business post-divestiture.
Baxter International Inc.
Key Product Line Sales by US and International
Three-Month Periods Ending June 30, 2008 and 2007
(unau
'/>"/>
| SOURCE Baxter International Inc. Copyright©2008 PR Newswire. All rights reserved |